Laboratorios Farma | ROVI - Cost Of Sales

Stock Price
82.45
Daily Change
-0.10 -0.12%
Monthly
-0.72%
Yearly
71.91%
Q2 Forecast
80.24

Laboratorios Farma reported EUR186.09M in Cost of Sales for its fiscal semester ending in December of 2023.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Almirall EUR 191.5M 2.29M Dec/2025
Avita Medical AUD 3.3M 166K Dec/2025
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Moderna USD 452M 245M Dec/2025
Organon & Co USD 745M 25M Sep/2025
Pharma Mar EUR 3.77M 1.47M Dec/2025
Revvity USD 350.4M 26.05M Dec/2025
Viatris USD 2.56B 167.3M Dec/2025
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025